Physician profile
Zoe Apted
NPI 1629500830
$4,831.31
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,118 · 2022: $1,756 · 2023: $1,496 · 2024: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,859 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,858.94 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,029.33 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $802.19 | 2021-2023 | |
| Regeneron Healthcare Solutions, INC. | $645.26 | 2021-2023 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $519.59 | 2023-2024 | Sotyktu |
| Pfizer INC. | $445.58 | 2021-2023 | |
| Genzyme Corporation | $293.32 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $198.00 | 2022-2023 | |
| Amgen INC. | $174.06 | 2021-2024 | Otezla |
| Incyte Corporation | $164.29 | 2022 | |
| Arcutis Biotherapeutics, INC. | $163.37 | 2023-2024 | Zoryve |
| Paratek Pharmaceuticals, INC. | $115.22 | 2021 | |
| Lilly USA, LLC | $70.11 | 2023 | Taltz |
| Janssen Biotech, INC. | $42.88 | 2023 | Tremfya |
| Galderma Laboratories, L.P. | $35.94 | 2023-2024 | Aklief, Oracea, Epsolay |
| Leo Pharma INC. | $29.25 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vyne Pharmaceuticals INC. | $26.25 | 2021 | |
| Ucb, INC. | $21.98 | 2023 | Cimzia |
| Dermavant Sciences, INC. | $19.00 | 2023 | Vtama |
| Hologic Sales and Service, LLC | $18.51 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $17.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zoe Apted listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.